Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Effector Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update

May 9 (Reuters) - Effector Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * EFFECTOR THERAPEUTICS-  HAD CASH, CASH EQUIVALENTS, AND
SHORT-TERM INVESTMENTS TOTALING $19.0 MILLION AS OF MARCH 31,
2023
    * EFFECTOR THERAPEUTICS- ANTICIPATES THAT CURRENT CASH, CASH
EQUIVALENTS & SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO FUND
OPERATIONS INTO Q1 OF 2024
    * QTRLY NET LOSS WAS $10.0 MILLION, OR $0.24 PER BASIC AND
DILUTED
SHARE
    * Q1 EARNINGS PER SHARE VIEW $-0.14 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8jYvh6 
Further company coverage:  EFTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news